Citing a surplus of alternative vaccines for COVID-19, AstraZeneca (LSE: AZN) is moving to withdraw its Vaxzevria jab from sale. Earlier in the year, AstraZeneca voluntarily withdrew its marketing ...

The news was first reported by The Telegraph. In an update on the European Medicines Agency website, the regulator said approval of the pharmaceutical giant's vaccine — Vaxzevria — has now been ...

AstraZeneca (NASDAQ:AZN) has declared a worldwide cessation of its COVID-19 vaccine, Vaxzevria, due to an “excess of updated vaccines.” What Happened: The company began the withdrawal process ...

New variants, many vaccines available and increasingly low demand: AstraZeneca decides to withdraw the Vaxzevria vaccine 08 05 2024 Flash: AstraZeneca withdraws the Covid-19 vaccine worldwide ...

LONDON (dpa-AFX) - AstraZeneca, a major provider of Covid-19 vaccines across the world mainly during the initial pandemic period, has initiated a process to withdraw its Vaxzevria COVID-19 vaccine ...

London (AFP) – Anglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing Covid vaccine Vaxzevria, one of the first produced in the deadly pandemic, citing "commercial reasons ...

“We are incredibly proud of the role Vaxzevria played in ending the global pandemic,” said the AstraZeneca spokesperson. Countries across the globe, including Malaysia, have opted for AstraZeneca as ...

May 17, 2024 — A study has found that repeat vaccination with updated versions of the COVID-19 vaccine promotes the development of antibodies that neutralize a wide range of variants of the ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) has recommended authorizing a version of BioNTech and Pfizer’s Comirnaty COVID-19 vaccine targeting the Omicron XBB.1.5 ...

One German man has redefined "man on a mission." CDC recommends seniors get another COVID-19 shot California eases COVID rules, mild cases no longer warrant isolation COVID JN.1 variant now ...